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ABSTRACT
Asthma is a chronic, inflammatory disease of the
airways that exacts a large burden of illness among
patients, their families, and the health-care system. Yet
advances in research have generated the means for
addressing this public health problem. The challenge
is to bridge the gap between excessive asthma morbid-
ity and the science that holds the promise of reducing
it; that is, to translate the scientific advances into
meaningful recommendations for clinical care and to
promote adoption of the recommendations. This
paper will demonstrate how national asthma educa-
tion programs, founded on science-based clinical
practice guidelines, meet this challenge and help
reduce illness and improve the quality of life for people
with asthma.
Key words: asthma, clinical practice guidelines,
guidelines, national asthma program.
INTRODUCTION
The burden of asthma
In the United States, asthma affects 15 million people,
and is the most common chronic disease of childhood.
In 1995, there were over 1 million hospitalizations with
asthma listed as the first or secondary diagnosis. As
shown in Fig. 1, age-adjusted hospitalization rates for
asthma, as a first-listed diagnosis, have remained fairly
constant since 1980. But it is of concern that the rate
among blacks is three and a half times that among whites,
and the rate among young children has increased. More
than 5000 people die of asthma annually. It is troubling
that the mortality rates have increased steadily over the
last 15 years following a 10-year decline, and that the
mortality rate among blacks is nearly twice that of whites.1
The reasons for the disparity are not entirely clear, but it is
likely that factors related to income and access to appro-
priate medical care contribute.
The burden of disease is also measured by quality of
life. Children with asthma miss an average of twice as
many school days as other children; 21% of children
with asthma miss over 2 weeks of school a year due to
asthma.2 Twenty-one percent of people of all ages with
asthma restrict their daily activities due to asthma
(Centers for Disease Control, National Center for Health
Statistics, National Health Interview Survey 1996). The
estimated direct and indirect monetary costs for asthma
totaled US$11.3 billion in 1998.3
Accentuating our concern over these rates of serious
illness due to asthma is the awareness that asthma prev-
alence rates for people of all ages doubled in the 
last 15 years (Fig. 2). The prevalence increased 160%
among children aged 0–4 and 74% among children aged
5–14 years.1
It is imperative, then, that measures be implemented to
address this serious and growing public health problem.
Fortunately, the tools are at hand to do so.
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The role of national asthma education
programs and clinical practice guidelines
Advances in scientific research have improved our under-
standing of the pathophysiology of asthma, and the
molecular and cellular events that contribute to it.4
Such research revealed the central role of inflammation
in asthma, helped identify appropriate targets for medical
intervention, and led to the development of new treat-
ments. If treated appropriately, most people with asthma
can now expect to live physically active and productive
lives with minimal disruption due to their asthma.
The National Heart, Lung, and Blood Institute (NHLBI),
as an agency of the US government’s Department of
Health and Human Services, is a scientific organization
supporting basic, clinical and health education research
on all heart, lung, and blood diseases. But the role of the
NHLBI is not only to support research in academic institu-
tions around the country. It is also to evaluate results from
the scientific literature and translate the research results 
to positively impact on public health. An effective means
to implement this mandate is through national education
programs. The NHLBI sponsors several separate programs,
for example, on high blood pressure and cholesterol, 
that have led to substantial reductions in heart disease
over the last 15 years. A National Asthma Education and
Prevention Program (NAEPP) was created in 1989 with
the goals of raising awareness among patients, health
professionals and the public that asthma is a serious
chronic lung disease, and to develop programs for
effective control and prevention of asthma. The NAEPP
Coordinating Committee, which provides overall dir-
ection to the national program, is composed of
representatives from more than 30 medical, professional
and voluntary health organizations, patient groups,
and government agencies (Table 1). This representation
ensures that groups and individuals who have major
responsibility in the US health-care system for educating
professionals and the public about asthma are directly
involved in planning the very programs they will be asked
to implement. By working together, consistent messages
about asthma and its care are developed, duplication of
effort is prevented, and partnerships are created among
organizations at both the national and local level to
enhance dissemination programs.
The initial task of the NAEPP was to develop clinical
practice guidelines for asthma to serve as the foundation
for all NAEPP education programs. Clinical practice
guidelines are systematically developed statements that
assist practitioners in making decisions about appropriate
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Fig. 1 Trends in asthma hospi-
talizations by race. (r), white;
(j), black; (m), other. Ages are
adjusted to the 1970 USA resi-
dent population. Data are from
the National Hospital Discharge
Survey, National Center for
Health Statistics.23
Fig. 2 Trends in asthma preva-
lence by age. (r), 0–4; (j),
5–14; (m), 15–34; (d), 35–64;
(+), 65 years of age and older.
Data are from the National Health
Interview Survey, National Center
for Health Statistics.24
health care for specific clinical conditions.5 As such, guide-
lines offer physicians, other health-care professionals, and
patients a synthesis of the most up-to-date management
strategies and a common reference point for communi-
cating with each other.
In 1991, the NAEPP published the first Expert Panel
Report: Guidelines for the Diagnosis and Management 
of Asthma,6 that emphasized four essential components
of asthma management: objective measures of lung
function to assess asthma severity and guide selection
of medications; a stepwise approach to pharmacologic
therapy that promotes adjusting the amount or number
of medications according to asthma severity and empha-
sizes the importance of anti-inflammatory therapy for
persistent asthma; environmental control measures to
avoid exposure to those factors (‘triggers’) in the environ-
ment that worsen asthma; and patient education to 
teach patients asthma-management skills and promote a
partnership between the patient, his or her family, and 
the clinician for managing asthma together.
THE DEVELOPMENT OF NATIONAL ASTHMA
EDUCATION AND PREVENTION PROGRAM
CLINICAL PRACTICE GUIDELINES
The NAEPP strives to assure the scientific validity, credibil-
ity and practical utility of its guidelines through several
mechanisms. As a federal government activity, the NAEPP
is independent of any single medical specialty or phar-
maceutical interest, and the wide membership of its
panels of experts and the Coordinating Committee pro-
vides the capacity for consensus building and extended
peer review that are deemed critical in producing credi-
ble guidelines. For example, the members of the panels
are selected for their research and clinical expertise in
different areas of asthma and its management so that
individual panels are composed of pulmonologists, aller-
gists, nurses, family physicians, pediatricians, emergency
medicine specialists, behavioral scientists, and health
educators. Further, each NAEPP Coordinating Commit-
tee member and his or her organization participates in
the review and endorsement of the guidelines, resulting in
the involvement of over 140 individuals from 40 public
and private organizations.
Expert Panel Report, 1991
There is a spectrum of models for organizing the devel-
opment of clinical practice guidelines.5 On one end of
the spectrum is the model that requires a formal and
extensive analysis of the literature, using quantitative
methodology such as meta-analyses, along with expert
judgment. This model frequently takes several years work,
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Table 1 National Asthma Education and Prevention
Program Coordinating Committee Member Organizations
Public Organizations
Allergy and Asthma Network/Mothers of Asthmatics
American Academy of Allergy, Asthma, and Immunology
American Academy of Family Physicians
American Academy of Pediatrics
American Academy of Physician Assistants
American Association for Respiratory Care
American Association of Occupational Health Nurses
American College of Allergy, Asthma, and Immunology
American College of Chest Physicians
American College of Emergency Physicians
American Lung Association
American Medical Association
American Nurses’ Association
American Pharmaceutical Association
American Public Health Association
American School Health Association
American Society of Health-System Pharmacists
American Thoracic Society
Association of State and Territorial Directors of Public Health
Education
Asthma and Allergy Foundation of America
National Association of School Nurses
National Black Nurses’ Association
NHLBI Ad Hoc Committee on Minority Populations
National Medical Association
Society for Public Health Education
Federal Agencies
Agency for Health Care Policy and Research
Centers for Disease Control and Prevention
National Center for Environmental Health
National Center for Health Statistics
National Heart, Lung, and Blood Institute
National Institute for Occupational Safety and Health
National Institute of Allergy and Infectious Diseases
National Institute of Environmental Health Sciences
US Environmental Protection Agency
US Food and Drug Administration
US Public Health Service
Additional Representatives to the NAEPP School Asthma
Education Subcommittee
American Alliance for Health, Physical Education, 
Recreation, and Dance
National Association of Elementary School Principals
National Education Association Health Information Network
National School Boards Association
NHBLI, National Heart, Lung and Blood Institute; NAEPP, National
Asthma Education and Prevention Program.
is very expensive, and has been most successfully used to
answer specific questions that have a limited scope. On
the other end of the spectrum is the consensus workshop
model, which brings together a small group of experts
who listen to scientific presentations for one day and
spend a second day preparing a written statement. For a
complicated disease like asthma, neither approach was
deemed appropriate. Accordingly, the NAEPP used a
combination of methods to create a process for reviewing
the literature and developing recommendations for clini-
cal care. The overriding principle of the development
process of the guidelines was to base recommendations
on the best available science. The members of the panels
divided responsibility for reviewing the literature indiv-
idually and their group meetings generated consensus
on either interpreting the science or articulating the
members’ expert opinion. Although sometimes open to
controversy, consensus opinions are valuable to further
scientific and clinical understanding of a condition,
particularly when data are inconclusive or lacking.
Expert Panel Report 2, 1997
No sooner had the 1991 guidelines been published 
than new literature became available. Over the next few
years, the complexity of asthma became increasingly
apparent, and the options for care had expanded rapidly.
Accordingly, in 1994 the NAEPP formed a Science-Based
Committee to examine all relevant research since 1991,
through MEDLINE searches. After review of over 6500
abstracts, the committee recommended that a total revi-
sion of the Expert Panel Report, 1991 was not warranted
because much of the new literature substantiated the rec-
ommendations the panel had originally made without
having numerous studies available. However, the
Committee identified selected areas for which an update
would be appropriate. For example, new medications
were available and there was more evidence about the
effectiveness and side effects of asthma therapies; a
significant upsurge of information about quality of life
measures as well as symptom and peak-flow monitoring
techniques merited consideration; there were new studies
about asthma in young children; and there was new
evidence regarding the role of allergy control measures
in asthma management.
An update to the Expert Panel Report, 1991 was rec-
ommended in 1995. It was agreed at the outset that
recommendations in the 1991 guidelines would not be
changed unless there was compelling evidence to do so.
This was essential to minimize confusion about a revision
and to reinforce the key messages about asthma man-
agement as much as the science allowed.
A more systematic, iterative process for reviewing the
literature was used by the second expert panel, in part to
accommodate the explosive increase in the number of
studies about asthma therapies. Subcommittees for each
of the four major areas in the Expert Panel Report, 1991
conducted a general review of research pertinent to rec-
ommendations in its section. Although a formal ranking
system was not used to weight the evidence, the panel
agreed that its recommendations would be documented
as much as possible by research published in peer-
reviewed journals; randomized clinical trials had
preference, but case studies and review articles also were
included. Where sufficient studies were not available, 
the panel used its expert opinions based on theory and
clinical experience. Clearly, some recommendations
were more thoroughly supportable than others; it is
important to remember that many questions regarding
the clinical management of asthma have not yet been
subjects of empiric research. The panel selected several
issues for which controversy or a significant body of new
literature existed for in-depth review. For example, in the
monitoring section, all the literature on peak-flow moni-
toring was ranked and reviewed according to its research
design and methods; in the pharmacology section
special safety issues regarding inhaled corticosteroids
and inhaled beta agonists were reviewed in detail, and a
dosage chart was created to give estimated comparative
daily dosages for inhaled corticosteroids since studies
revealed that inhaled corticosteroid preparations are not
equivalent on a per-puff or per-microgram basis.
Once the subcommittee reports were drafted, the full
panel critically reviewed the evidence and rationale for
each recommendation, and discussed revision, reaching
final agreement on each recommendation through a
voting process. The panel then forwarded its draft report
to all members of the NAEPP Coordinating Committee
for review. Revisions to the draft were made to incorpo-
rate as many suggestions made by the Coordinating
Committee as possible, in light of the scientific review
and consensus of the panel. This review cycle was essen-
tial because it helped assure that representatives from key
affected audiences were a part of the report’s develop-
ment. This enhanced the credibility and, importantly, 
the feasibility of the recommendations. The Expert Panel
Report 2 was published in 1997.7
Refinements in the format of the report were made in
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order to make the guidelines easier for busy clinicians
to use. For example, all recommendations appeared in
boldfaced text to separate the specific recommendation
from the text explaining its rationale. Recommendations
were accompanied by either a specific citation of studies
that supported the recommendation or by an indication
that the recommendation was based on the opinion of
the panel. Each chapter was prefaced with a list high-
lighting the significant changes from the first report.
Summary charts geared to primary care physicians and
sample patient education materials were presented as
integral to the guidelines. A practical guide was prepared
to summarize key recommendations. Laminated cards
were created to present the recommendations for step-
wise therapy, essentially distilling asthma-management
strategies onto two cards. Such summaries meet the
perceived need among primary care clinicians for easy-
to-use reference charts. However, there was some
concern that charts may oversimplify information and
inadequately reflect the differing levels of certainty and
scientific support that accompany different recom-
mendations within the chart. Thus, it was felt that it was
important to remind clinicians that the guidelines are not
intended to be inflexible prescriptions for care, but rather
to provide general guidance, based on the best available
scientific evidence, to improve clinical decision-making.
Future updates
Developing guidelines is a dynamic process: as research
continues, so too does the need to translate the findings
into useful public information. Therefore, publication of
the Expert Panel Report 2 marked the beginning of a new
round of discussions for the Science-Based Committee to
continue to monitor the scientific literature for advances
that may signal a need to update the guidelines yet
again. The NHLBI has searched for ways to monitor the
literature on an ongoing basis rather than at 3–5 year
intervals, and to update relevant sections of the report in
a more timely way. Working with the National Library of
Medicine, the NHLBI is building an evidence-based
computer model for scientific review and clinical practice
guidelines revision. This computer-accessed model,
called the Asthma Management Model System, sorts 
and stores scientific literature in categories of asthma
management and research analogous to the four com-
ponents of therapy that comprise the organizational
framework for the Expert Panel Reports. Researchers and
clinicians can ask search questions through the computer
program that will link newly published evidence of speci-
fied therapies to designated patient outcomes. The
searcher can also be linked to ongoing research sup-
ported by the National Institutes of Health (NIH). Emerging
trends can be readily identified and the Science-Based
Committee can recommend brief reviews for selected
topics. The position papers can then be labeled ‘new
updates’ and integrated into the guidelines that are stored
in the Asthma Management Model System.
DISSEMINATING AND IMPLEMENTING
THE GUIDELINES
Dissemination activities
Preparation of the guidelines is just the first step in the
research translation process. A wide range of activities
is necessary to disseminate the guidelines and promote
their adoption. Through its member organizations, the
NAEPP has mailed over 500 000 copies of its reports
and distributed them widely at national professional
society meetings. An important additional dissemination
strategy has been to incorporate the guidelines into
documents tailored to special audiences, such as the
different specialities in the medical profession, as well
as patients and the public. For example, the NAEPP has
worked with nurses, emergency department physicians,
pharmacists, and consumer groups to prepare special
editions of the guidelines. Because asthma is a prominent
problem among school children and frequently disrupts
school activities, the NAEPP has targeted information
directly at school teachers, staff and families, in order to
promote adequate management of asthma in the school
environment and to encourage children to participate
fully in all school activities, including physical education
and sport. Patient booklets have also been developed
(Your Asthma Can Be Controlled, Expect Nothing Less,
and Facts about Controlling your Asthma), and patient
advocacy groups within the NAEPP sponsor bimonthly
patient newsletters. Public information campaigns,
through radio announcements and billboard advertise-
ments, have alerted the public to the importance of
recognizing asthma as a serious disease, and identifying
its symptoms and seeking medical advice.
Educational programs to promote
implementation
Simple dissemination of guidelines and information is
certainly a necessary foundation for improving the quality
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of asthma care, but it is seldom sufficient to create lasting
changes in physician and patient behavior. A recent
survey reminds us of this principle. In a national tele-
phone survey of 2000 people in the USA with asthma 
and 512 physicians, a comparison was made between
patients’ reports about their disease and the goals for
asthma management stated in the Expert Panel Report 2.
The survey revealed that 49% of children with asthma and
25% of adults missed school or work due to asthma,
whereas the goal is to have no absences. And 41% of
persons with asthma had required urgent medical care in
a doctor’s office or emergency department, whereas the
goal is to have minimal need for emergency department
visits. Significantly, only 35% of asthma patients in the
survey reported having had a lung-function test in the
past year, and only 27% of the patients said they had
been given a written action plan for managing their
asthma, and yet objective measures of assessment and
written treatment plans are strongly recommended in the
guidelines. The survey also revealed that patients had a
tendency to underestimate the severity of their disease,
and to settle for levels of asthma control that were clearly
short of the expectations for care promulgated by the
guidelines (Press Release: Ogilvy Public Relations World-
wide, October 6, 1998).
While surveys have inherent methodologic drawbacks,
the overall message is clear: there is still much work to do
to improve asthma management and the quality of life for
people with asthma. The message from this survey is not
that guidelines do not work; the message is a reminder
that educational strategies must not stop at mere transfer
of information. Indeed, research studies have demon-
strated that clinical outcomes have improved through
good guidelines-implementation programs;8 for example,
decreased anticoagulant-related bleeding,9 lower ces-
arian section rates,10 improved health for patients with
diabetes,11 and shortened stays in the hospital.12 A review
of 59 rigorous evaluations of clinical practice guidelines
for a variety of medical conditions concluded that guide-
lines improve clinical practice and achieve health gains
for patients, but they are most likely to be effective when
they are scientifically valid, when they are introduced in
the context of an interactive education and evaluation
program, and when they help integrate the recommenda-
tions into the patient’s care routines.13 Examples of
effective implementation strategies include interactive
training programs using academic opinion leaders,14
computer-generated prompts in patient-encounter forms
that remind the clinician to ask specific questions or
perform certain tests,13,15 and embedding protocols from
guidelines into medical records (e.g., emergency-depart-
ment treatment and discharge checklists that conform to
the guidelines). Computer-based audits and feedback
comparing a physician’s patient-care practices with
national guidelines are also effective.16
Although there are few studies evaluating how effective
clinical-practice guidelines for asthma have been in
changing clinician behavior, the conclusions in five
reports17–21 were similar: guidelines influenced behavior
change among clinicians, but only with targeted, and
fairly intensive, educational programs. One study in a
primary care setting emphasized the need to include all
members of the clinic staff, not just the physicians, in the
implementation program to reinforce behaviors among
the staff, and to provide consistent messages and re-
inforcement directly to the patients.17 All the studies
indicated the need for multiple educational strategies,
repetition of key messages, and reinforcement for imple-
menting the guidelines.
The NAEPP encourages use of these principles of
implementation in its educational efforts. For example, 
a recent partnership project with the Academy of Allergy,
Asthma and Immunology is focused on promoting best
clinical practices among clinicians who care for children
with asthma. A special guide has been prepared that
extracts the information on treating asthma in children
from the Expert Panel Report 2 and provides additional
information about community resources for improving
asthma health-care systems for children. The guide will
be disseminated through regional workshops around the
USA, using interactive, problem-based medical learning
techniques. The NAEPP programs targeted at school
audiences include strategies to stimulate action. The
NAEPP works with organizations that govern schools to
foster appropriate school-wide policies; for example,
adoption of school record forms that include written
asthma treatment plans for each student with asthma,
and rules allowing students to carry their inhalers with
them during school hours. A NAEPP checklist, ‘How
Asthma Friendly is Your School?’, serves as an assess-
ment tool for teachers, administrators and parents to
evaluate how well the school follows recommended
asthma management strategies that enable a child with
asthma to participate fully in school activities. A further
example of implementation programs oriented towards
creating changes in clinician behavior is the 1998 NAEPP
conference of clinicians, administrators and educators
working in managed-care settings. Participants facilitated
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the design of quality assurance programs and strategies in
order to implement them once they returned to their
medical centers, and made recommendations for the devel-
opment of nationwide performance indicators to enhance
implementation of guidelines in various managed-care 
settings.
Actual change in clinical practice and patient behavior,
however, must be accomplished at the local level: where
clinicians practice and patients live. It is unrealistic to
educate patients about asthma self-management skills
if they are not prescribed appropriate medications. A
superb treatment plan is useless if a patient cannot afford
the medication, a family cannot get to a pharmacy before
it closes, a child cannot easily get to his medication
during school hours, or a person works in a building
where smoking is permitted. Programs are needed that
encourage system-wide approaches to asthma manage-
ment at the local community level.
A new NAEPP education and outreach effort focuses
on developing networks of community-based groups at
the local level. These groups, which are often called
Community Asthma Coalitions, are defined as broad-
based, multi-organizational, community partnerships that
bring together the public, private, and non-profit sectors
for a prolonged period in an effort to reduce asthma
morbidity and mortality, and improve quality of life for
asthma patients and their families. Local asthma coali-
tions develop goals and objectives that meet the needs
of their own communities. The coalitions are typically
composed of members from local public health depart-
ments, hospital/medical centers, community clinics,
schools, community recreation centers, church groups,
pharmacies, concerned patient groups, local chapters of
voluntary allergy or lung associations, city and county
government officials, and local media. One of the
earliest coalitions demonstrates a successful community
intervention model. The group started with a small
federal grant and conducted professional and patient
education programs at work sites, schools, hospitals and
clinics. Now, 3 years later, through the support of local
foundations and private businesses, the group is self-
sustaining.22 A more recently formed coalition in a large
USA city with particularly high asthma morbidity and 
mortality rates has organized over 50 organizations to
share information through newsletters and a specially
designed resource directory, and to influence change in
community systems. For example, the coalition’s efforts
changed school policies on asthma medications, and it 
is now working with pharmaceutical companies and
pharmacists to improve the accessibility and availability
of medications to patients.
The NAEPP held a conference in 1998 called
‘Strengthening asthma coalitions: Thinking globally,
acting locally’, which brought together over 50 coalitions
from across the country to exchange information and
define ways the NAEPP could help the local groups do
their work effectively. At the conference, the coalitions
demonstrated the value of building their programs on
standardized messages of the NAEPP. Ideas were gen-
erated to help them learn how to implement key
information from the guidelines in practical, concise
learning aides (such as algorithms) for primary care clini-
cians in their locality, and suggestions were shared on
making patient education materials sensitive to the needs
and interests of different cultural and ethnic groups in 
the respective communities. The coalitions expressed a
desire for an information clearinghouse, and for help
adapting national media campaigns to local city cam-
paigns. The NAEPP will work with the coalitions to
address these needs. As an initial response to the con-
ference, the NAEPP has created an Asthma Coalition
Exchange page contained within the NAEPP Asthma
Management Model System website mentioned earlier.
Through this site, coalitions can learn about each other,
communicate through discussion forums, and join a
coalition internet mailing list.
The Asthma Management Model System (AMMS)
embodies the entire spectrum of NHLBI asthma research
and research translation, and education activities. The
site, launched on World Asthma Day in December 1998,
can be accessed through the NHLBI home page at
<http://www.nhlbi.nih.gov>. The site brings together
three high-technology functions within one integrated
system to help health-care professionals, researchers,
public health planners, and patients reduce the burden of
asthma. Through the research function, the interactive
AMMS lets users quickly formulate research questions
and access key databases. The user can formulate, for
example, questions about what effects a selected treat-
ment will have on a selected patient for whom selected
conditions are known. The system then retrieves relevant
information from such major scientific databases as
MEDLINE, CRISP and CORDIS, as well as documents
from the Food and Drug Administration and Centers for
Disease Control. Hyperlinks send the user to the relevant
section of the NAEPP guidelines and the Global Initiative
for Asthma (GINA). The education function allows the 
site user to retrieve the latest treatment guidelines, 
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browse and download materials for professional and
patient education, and engage in interactive educational
programs for university-certified continuing medical edu-
cation credits.
This up-to-date informatics technology allows for more
rapid translation of research findings into clinical prac-
tice. It also helps to monitor the literature to identify gaps
in the science and set priorities for future research.
The dynamic nature of the guidelines process (namely,
the translation of research to improve clinical care, and
the continuing cycle of transforming clinical questions
into new research initiatives) is perhaps its most important
value. When we celebrated the 50th Anniversary of the
NHLBI in 1998, we were able to announce that effective
control of asthma was a possibility for most patients. With
the national guidelines and education programs in place
and supported by state-of-the-art information technol-
ogy, and with the continued support of research, we can
look forward to announcing within the next 50 years that
effective control of asthma is a reality for all patients, 
and that the opportunity for preventing the onset of the
disease is at hand.
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